Xinxian Weng
Key Laboratory Of Carcinogenesis
Changsha, 410078, China
Changsha, 410078, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
IDH2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancer.
Journal: Molecular oncology
Published: June 27, 2017
Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancer.
Journal: Theranostics
Published: June 19, 2017
Neoalbaconol inhibits angiogenesis and tumor growth by suppressing EGFR-mediated VEGF production.
Journal: Molecular carcinogenesis
Published: May 04, 2016
EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma.
Journal: Cancer letters
Published: March 24, 2016
A new functional IDH2 genetic variant is associated with the risk of lung cancer.
Journal: Molecular carcinogenesis
Published: February 28, 2016
Evaluation of a dansyl-based amino acid DNSBA as an imaging probe for apoptosis detection.
Journal: Apoptosis : an international journal on programmed cell death
Published: January 19, 2015
AID expression increased by TNF-α is associated with class switch recombination of Igα gene in cancers.
Journal: Cellular & molecular immunology
Published: August 11, 2014
A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: November 18, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026